Abstract |
'Pulsed' immunosuppressive therapy, using methylprednisolone with or without cyclophosphamide, has effectively controlled severe destructive corneal and scleral disease that had been unresponsive to oral steroids. Thirty-seven patients have been treated in this manner and the results, complications and possible mechanism of action are discussed.
|
Authors | P A Meyer, P G Watson, W Franks, P Dubord |
Journal | Eye (London, England)
(Eye (Lond))
Vol. 1 ( Pt 4)
Pg. 487-95
( 1987)
ISSN: 0950-222X [Print] England |
PMID | 3443202
(Publication Type: Journal Article)
|
Chemical References |
- Immunosuppressive Agents
- Cyclophosphamide
- Methylprednisolone
|
Topics |
- Aged
- Corneal Diseases
(drug therapy)
- Cyclophosphamide
(adverse effects, therapeutic use)
- Drug Therapy, Combination
- Female
- Humans
- Immunosuppressive Agents
(therapeutic use)
- Inflammation
(drug therapy)
- Infusions, Intravenous
- Male
- Methylprednisolone
(adverse effects, therapeutic use)
- Middle Aged
- Sclera
|